Application of Latent Growth Curve modeling to predict individual trajectories during neurofeedback treatment for tinnitus.
Electroencephalography
Latent-Growth Curve Modeling
Neurofeedback
Oscillation
Predictors
Resting-state
Subject-specific treatment
Journal
Progress in brain research
ISSN: 1875-7855
Titre abrégé: Prog Brain Res
Pays: Netherlands
ID NLM: 0376441
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
10
7
2021
pubmed:
11
7
2021
medline:
25
11
2021
Statut:
ppublish
Résumé
Tinnitus is a heterogeneous phenomenon indexed by various EEG oscillatory profiles. Applying neurofeedback (NFB) with the aim of changing these oscillatory patterns not only provides help for those who suffer from the phantom percept, but a promising foundation from which to probe influential factors. The reliable attribution of influential factors that potentially predict oscillatory changes during the course of NFB training may lead to the identification of subgroups of individuals that are more or less responsive to NFB training. The present study investigated oscillatory trajectories of delta (3-4Hz) and individual alpha (8.5-12Hz) during 15 NFB training sessions, based on a Latent Growth Curve framework. First, we found the desired enhancement of alpha, while delta was stable throughout the NFB training. Individual differences in tinnitus-specific variables and general-, as well as health-related quality of life predictors were largely unrelated to oscillatory change prior to and across the training. Only the predictors age and sex at baseline were clearly related to slow-wave delta, particularly so for older female individuals who showed higher delta power values from the start. Second, we confirmed a hierarchical cross-frequency association between the two frequency bands; however, in opposing directions to those anticipated in tinnitus. The establishment of individually tailored NFB protocols would boost this therapy's effectiveness in the treatment of tinnitus. In our analysis, we propose a conceptual groundwork toward this goal of developing more targeted treatment.
Identifiants
pubmed: 34243885
pii: S0079-6123(21)00104-7
doi: 10.1016/bs.pbr.2021.04.013
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT02383147']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109-136Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.